Lexicon Pharmaceuticals
LXRX
LXRX
131 hedge funds and large institutions have $1.31B invested in Lexicon Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 52 increasing their positions, 31 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
10% less capital invested
Capital invested by funds: $1.46B → $1.31B (-$148M)
Holders
131
Holding in Top 10
2
Calls
$8.78M
Puts
$3.35M
Top Buyers
| 1 | +$10.4M | |
| 2 | +$7.64M | |
| 3 | +$3.1M | |
| 4 |
Millennium Management
New York
|
+$2.73M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$2.66M |
Top Sellers
| 1 | -$14.7M | |
| 2 | -$4.95M | |
| 3 | -$2.99M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$2.27M |
| 5 |
SIP
Stoneridge Investment Partners
Radnor,
Pennsylvania
|
-$2.16M |